Status:
UNKNOWN
Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure
Lead Sponsor:
Harbin Medical University
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
20-70 years
Brief Summary
The purpose of this study is to explore the efficacy of low energy cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.
Detailed Description
The purpose of this study is to explore the efficacy of low energy (30J) cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.
Eligibility Criteria
Inclusion
- congestive heart failure accompanied by atrial fibrillation.
Exclusion
- Valvular heart diseases.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02292030
Start Date
November 1 2014
End Date
October 1 2015
Last Update
November 17 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ren Xiaohui
Harbin, Heilongjiang, China, 150001
2
the first affiliated hospital of Harbin Medical University
Harbin, Heilongjiang, China, 150001